Market Tracker

12/02 5:16pm ET

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

5.27
Delayed Data
As of Dec 02
 +0.17 / +3.33%
Today’s Change
4.39
Today|||52-Week Range
9.35
-33.29%
Year-to-Date
No recent news for Merrimack Pharmaceuticals Inc.

Today’s Trading

Previous close5.10
Today’s open5.11
Day’s range5.05 - 5.30
Volume1,737,153
Average volume (3 months)2,954,077
Market cap$683.1M
Dividend yield--
Data as of 4:00pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)-66.25%
Earnings growth (this year)+2.51%
Earnings growth (next 5 years)+5.61%
Revenue growth (last year)-13.14%
P/E ratioNM
Price/Sales9.86
Price/Book--

Competitors

 Today’s
change
Today’s
% change
VNDAVanda Pharmaceutical...+0.10+0.65%
ARDXArdelyx Inc+0.70+4.96%
SCMPSucampo Pharmaceutic...-0.35-2.22%
GBTGlobal Blood Therape...-0.10-0.52%
Data as of 4:00pm ET, 12/02/2016

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$89.3M
Annual profit (last year)-$148.0M
Net profit margin-165.76%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Gary L. Crocker
Head-
Corporate Operations
William M. McClements
Corporate headquarters
Cambridge, Massachusetts

Forecasts